STOCK TITAN

Elixxer Announces Results of Annual and Special Meeting of Shareholders

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Elixxer (TSXV: ELXR) held its annual and special meeting of shareholders on March 20, 2025, with 56.44% of outstanding shares represented (6,400,078 shares). Key approvals included:

- Appointment of CAN Partners LLP as new auditors with 99.99% approval, replacing MS Partners LLP who resigned February 18, 2025
- Change of registered office from Quebec to Ontario
- Conversion of fixed stock option plan to rolling stock option plan
- Repeal of existing by-laws and enactment of new by-law no. 1

All matters presented were approved by an overwhelming majority of shareholders.

Elixxer (TSXV: ELXR) ha tenuto la sua riunione annuale e straordinaria degli azionisti il 20 marzo 2025, con il 56,44% delle azioni in circolazione rappresentate (6.400.078 azioni). Le approvazioni chiave includevano:

- Nomina di CAN Partners LLP come nuovi revisori contabili con il 99,99% di approvazione, in sostituzione di MS Partners LLP che si è dimessa il 18 febbraio 2025
- Cambio della sede legale da Quebec a Ontario
- Conversione del piano di opzioni azionarie fisse in un piano di opzioni azionarie rolling
- Abrogazione delle norme esistenti e adozione della nuova norma n. 1

Tutte le questioni presentate sono state approvate da una schiacciante maggioranza di azionisti.

Elixxer (TSXV: ELXR) celebró su reunión anual y especial de accionistas el 20 de marzo de 2025, con el 56,44% de las acciones en circulación representadas (6.400.078 acciones). Las aprobaciones clave incluyeron:

- Nombramiento de CAN Partners LLP como nuevos auditores con un 99,99% de aprobación, reemplazando a MS Partners LLP que renunció el 18 de febrero de 2025
- Cambio de oficina registrada de Quebec a Ontario
- Conversión del plan de opciones sobre acciones fijas a un plan de opciones sobre acciones continuas
- Derogación de los estatutos existentes y promulgación del nuevo estatuto n.º 1

Todos los asuntos presentados fueron aprobados por una abrumadora mayoría de accionistas.

Elixxer (TSXV: ELXR)는 2025년 3월 20일 주주 연례 및 특별 회의를 개최하였으며, 발행된 주식의 56.44%가 대표되었습니다 (6,400,078주). 주요 승인 사항은 다음과 같습니다:

- CAN Partners LLP를 새로운 감사인으로 임명하며 99.99%의 승인으로 MS Partners LLP를 대체하였고, MS Partners LLP는 2025년 2월 18일 사임하였습니다.
- 등록 사무소를 퀘벡에서 온타리오로 변경
- 고정 주식 옵션 계획을 롤링 주식 옵션 계획으로 전환
- 기존 정관을 폐지하고 새로운 정관 제1호를 제정

제출된 모든 사항은 압도적인 주주 다수에 의해 승인되었습니다.

Elixxer (TSXV: ELXR) a tenu sa réunion annuelle et spéciale des actionnaires le 20 mars 2025, avec 56,44 % des actions en circulation représentées (6 400 078 actions). Les approbations clés comprenaient :

- Nommer CAN Partners LLP en tant que nouveaux auditeurs avec une approbation de 99,99 %, remplaçant MS Partners LLP qui a démissionné le 18 février 2025
- Changement de bureau enregistré du Québec à l'Ontario
- Conversion du plan d'options d'actions fixes en plan d'options d'actions roulantes
- Abrogation des règlements existants et adoption du nouveau règlement n° 1

Toutes les questions présentées ont été approuvées par une écrasante majorité d'actionnaires.

Elixxer (TSXV: ELXR) hielt am 20. März 2025 seine jährliche und außerordentliche Hauptversammlung der Aktionäre ab, bei der 56,44% der ausstehenden Aktien vertreten waren (6.400.078 Aktien). Wichtige Genehmigungen umfassten:

- Ernennung von CAN Partners LLP als neue Wirtschaftsprüfer mit einer Zustimmung von 99,99%, die MS Partners LLP ersetzt, die am 18. Februar 2025 zurückgetreten ist.
- Änderung des eingetragenen Büros von Quebec nach Ontario
- Umwandlung des festen Aktienoptionsplans in einen rollierenden Aktienoptionsplan
- Aufhebung der bestehenden Satzungen und Verabschiedung der neuen Satzung Nr. 1

Alle vorgelegten Angelegenheiten wurden von einer überwältigenden Mehrheit der Aktionäre genehmigt.

Positive
  • High shareholder participation with 56.44% of shares represented
  • Strong shareholder support with overwhelming majority approval on all matters
Negative
  • Resignation of previous auditor MS Partners LLP

Toronto, Ontario--(Newsfile Corp. - March 25, 2025) - Elixxer Ltd. (TSXV: ELXR) ("Elixxer" or the "Company) is pleased to announce the results of its annual and special meeting of shareholders (the "Meeting") held on March 20, 2025.

A total of 6,400,078 shares were voted at the Meeting in person or by proxy, representing 56.44% of the votes attached to all of the Company's issued and outstanding common shares. All matters submitted to shareholders for approval as set out in the Company's Notice of Meeting and Management Information Circular dated February 10, 2025, were approved by an overwhelming majority of votes cast at the Meeting.

At the Meeting, management presented to the shareholders its nominees for election as directors. The following individuals were elected to serve as directors of the Company until the next annual meeting:

NameVotes in FavourVotes Withheld/Abstained
Ferras Zalt6,390,824 (99.86%)9,251 (0.14%)
Jayahari Balasubramaniam6,391,925 (99.87%)8,150 (0.13%)
Alexey (Alex) Kanayev6,394,670 (99.92%)5,405 (0.08%)
Mark E. Romano6,393,973 (99.90%)6,102 (0.10%)
Edward Milewski6,393,972 (99.90%)6,103 (0.10%)

 

At the Meeting, shareholders were asked to approve the appointment of CAN Partners LLP, Chartered Professional Accountants, as the Company's auditors for the ensuing year replacing MS Partners LLP who resigned on February 18, 2025. According to votes cast, CAN Partners LLP was appointed as the Company's auditors with 99.99% of the votes in favour.

At the Meeting, shareholders were asked to approve a special resolution to amend the articles of the incorporation of the company to change the province in which the registered office of the Company is located from the Province of Quebec to the Province of Ontario. The special resolution was approved by an overwhelming majority of shareholders and the results of the votes cast were as follows:

Votes in FavourVotes Against
6,396,554 (99.94%)3,521 (0.06%)

 

At the Meeting, shareholders were asked to approve a resolution to approve and confirm the conversion of the Company's existing "fixed" stock option plan to a "rolling" stock option plan. The amendment to the Stock Option Plan was approved by an overwhelming majority of shareholders at the Meeting as follows:

Votes in FavourVotes Against
6,394,761 (99.92%)5,314 (0.08%)

 

Finally, at the Meeting, shareholders also passed a resolution confirming the repeal of all existing by-laws of the Company and the enactment of a new by-law no. 1 of the Company. The resolution in respect of the enactment of the New By-Law No 1 was approved by an overwhelming majority as follows:

Votes in FavourVotes Against
6,385,389 (99.77%)14,686 (0.23%)

 

About Elixxer Ltd.

Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSXV: ELXR) and the US OTC-Pink exchange (OTC Pink: ELIXF). Elixxer is an investment company with investments in Canada and other countries and is currently looking for new high growth opportunities to invest in.

Website: https://elixxer.ca/

For further information please contact:
Karim Mecklai, Chief Executive Officer, 416-877-3153

Caution Regarding Press Releases

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/245939

FAQ

What was the voter turnout at Elixxer's (ELIXF) 2025 annual meeting?

The meeting had 6,400,078 shares voted, representing 56.44% of the company's total outstanding shares.

Why did Elixxer (ELIXF) change auditors in 2025?

MS Partners LLP resigned on February 18, 2025, and shareholders approved CAN Partners LLP as new auditors with 99.99% approval.

What major changes were approved at Elixxer's (ELIXF) March 2025 shareholder meeting?

Shareholders approved changing the registered office from Quebec to Ontario, converting to a rolling stock option plan, and enacting a new by-law.

How will Elixxer's (ELIXF) stock option plan change after the 2025 meeting?

The plan will convert from a 'fixed' to a 'rolling' stock option plan, as approved by shareholders.
Elixxer

OTC:ELIXF

ELIXF Rankings

ELIXF Latest News

ELIXF Stock Data

10.14M
7.57M
33.21%
32.04%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Montreal